Learning Objectives:

1. Review standard of care for unresectable cholangiocarcinoma

2. Highlight advances in understanding genetic basis of chloangiocarcinoma

3. Explore data of agents targeting FGFR2, IDH1/2 and BRAF


Session date: 
Monday, April 27, 2020 - 12:00pm to 1:00pm
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Michael J. Breen, MD